相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5
John B. Buse et al.
DIABETES CARE (2016)
Randomized double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4
T. Blevins et al.
DIABETES OBESITY & METABOLISM (2016)
Basal insulin peglispro versus insulin glargine in insulin-naive type 2 diabetes: IMAGINE 2 randomized trial
M. J. Davies et al.
DIABETES OBESITY & METABOLISM (2016)
Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3
R. M. Bergenstal et al.
DIABETES OBESITY & METABOLISM (2016)
A randomized clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 1
S. Garg et al.
DIABETES OBESITY & METABOLISM (2016)
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Marja-Riitta Taskinen et al.
ATHEROSCLEROSIS (2015)
Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids
Daniel F. Vatner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
Klaus G. Parhofer
DIABETES & METABOLISM JOURNAL (2015)
Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism
Mary Courtney Moore et al.
DIABETES (2014)
Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects
Robert R. Henry et al.
DIABETES CARE (2014)
Steady-state pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 dosed once-daily in patients with type 2 diabetes mellitus
V. P. Sinha et al.
DIABETES OBESITY & METABOLISM (2014)
Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes A randomized, crossover study
Julio Rosenstock et al.
DIABETES CARE (2013)
A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes
Richard M. Bergenstal et al.
DIABETES CARE (2012)
Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes
A. Chaudhuri et al.
DIABETES OBESITY & METABOLISM (2011)
Insulin effects in muscle and adipose tissue
George Dimitriadis et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans
Helene Duez et al.
CIRCULATION (2008)
分享论文
